Copyright: ©Author(s) 2026.
World J Gastroenterol. Jan 21, 2027; 33(3): 123331
Published online Jan 21, 2027. doi: 10.3748/wjg.123331
Published online Jan 21, 2027. doi: 10.3748/wjg.123331
Figure 1 Trial profile.
RT: Radiotherapy; CRT: Chemoradiotherapy; PSM: Propensity score matching; CG: Control group.
- Citation: Feng GJ, Fu CR, Wang F, Li JC, Jiang Y, Wang XY, Yang BH, Xu WC, Zhang YW, Cheng XY, Ge XL, Xia XJ, Xi HM, Zhao XS, Ma HB, Zhao XX, Wang X, Li BS. Anlotinib plus radiotherapy or chemoradiotherapy in locally advanced or advanced esophageal squamous cell carcinoma: A multicohort, real-world study. World J Gastroenterol 2027; 33(3): 123331
- URL: https://www.wjgnet.com/1007-9327/full/v33/i3/123331.htm
- DOI: https://dx.doi.org/10.3748/wjg.123331